ABN AMRO Investment Solutions’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
ABN AMRO Investment Solutions's EXAS Position: Q1 2024 in Review
ABN AMRO Investment Solutions sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 17,062 shares — an estimated $1.26M sold.
ABN AMRO Investment Solutions first reported a position in EXAS in Q2 2023 and held it in 3 quarters. The position peaked at $1.26M in Q4 2023. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.
- ABN AMRO Investment Solutions reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
- ABN AMRO Investment Solutions sold 17,062 Exact Sciences shares in Q1 2024, an estimated $1.26M.
- ABN AMRO Investment Solutions first reported a position in Exact Sciences in Q2 2023 and held it in 3 quarters.
- ABN AMRO Investment Solutions's Exact Sciences position peaked at $1.26M in Q4 2023.
- 627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.
Based on ABN AMRO Investment Solutions's 13F filing for Q1 2024, filed 5 Sep 2025.